Osteoporosis management in the new millennium. Prim Care 2003 Dec;30(4):711-41, vi-vii
Date
03/18/2004Pubmed ID
15024893DOI
10.1016/s0095-4543(03)00090-3Scopus ID
2-s2.0-0345802815 (requires institutional sign-in at Scopus site) 11 CitationsAbstract
The prevalence of osteoporosis in all US postmenopausal women is 17%, and it is as high as 30% in women older than 65. All postmenopausal women should be encouraged to have adequate daily calcium and vitamin D intake, to exercise regularly, and to avoid tobacco and excessive alcohol use. Although the clinical impact and cost-effectiveness of osteoporosis screening tools remain to be established, a rational approach based on current evidence involves using National Osteoporosis Foundation guidelines, Simple Calculated Osteoporosis Risk Estimation, or Osteoporosis Risk Assessment Instrument clinical decision rules to decide when a postmenopausal woman should undergo further evaluation.
Author List
Wei GS, Jackson JL, Hatzigeorgiou C, Tofferi JKAuthor
Jeffrey L. Jackson MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AlendronateBone Density
Calcitonin
Calcium
Estrogens
Etidronic Acid
Exercise
Humans
Middle Aged
Osteoporosis, Postmenopausal
Raloxifene Hydrochloride
